90/012,6572-(N-METHYL-PROPANAMINE)-3-(2-NAPHTHOL)THIOPHENE, AN IMPURITY OF DULOXETINE HYDROCHLORIDE7,759,500Closed
Status
Reexamination Certificate Issued
Requester
Unknown
Requester Law Firm
Requested By
Third Party
Patent OwnerInferred
P.O. Law Firm
Reexam History (25 events)
Aug 23, 2013REEXInput Issue Number and Issue Date for Reexamination
Aug 14, 2013RXPUBSReexam Forwarded to Office of Publications
Aug 9, 2013MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Jul 31, 2013RXLITSRReexam Litigation Search Conducted
Jul 10, 2013RXFWDXDate Forwarded to Examiner
May 9, 2013MR.NFRX - Mail Reexam Non-Final Action
Mar 19, 2013RXFWDXDate Forwarded to Examiner
Feb 12, 2013NRX.Notice of Reexam Published in Official Gazette
Feb 7, 2013WIDSInformation Disclosure Statement (IDS) Filed
Feb 7, 2013IDSCInformation Disclosure Statement considered
Jan 17, 2013MREXORX - Mail Ex Parte Request for Reexamination Granted
Nov 19, 2012MREXNRX - Mail Examiner Interview Summary Record
Nov 13, 2012DOCKCase Docketed to Examiner in GAU
Nov 9, 2012RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Nov 9, 2012RXNREQFDNotice of reexamination request filing date
Nov 9, 2012RXNREQAUNotice of assignment of reexamination request
Nov 9, 2012RXLITSRReexam Litigation Search Conducted
Nov 9, 2012MRXNReexamination Formalities Notice Mailed
Nov 9, 2012MRXNReexamination Formalities Notice Mailed
Nov 8, 2012RXOSUCOrig Req Receipt Corrected
Nov 8, 2012RXC/SRCertificate of Service
Oct 10, 2012MRICRRX - Mail Notice of Incomplete Ex Parte Reexam Request
Oct 9, 2012RXTTLRPTTitle Report
Sep 14, 2012RXOSUB.RReexamination requested by third party requester
Sep 14, 2012RXOSUBReceipt of Original Ex Parte Reexam Request
Prosecution, PTAB & CAFC
PTAB Proceedings (IPR, PGR, CBM, DER)
None found
Federal Circuit (CAFC)
None found
Terminal Disclaimer
None found
Prosecution History
None found
Maintenance Fees
Grant
Jul 20, 2010
3.5-yr
Jan 20, 2014
7.5-yr
Jan 20, 2018
11.5-yr
Jan 20, 2022
Expiry
Nov 20, 2028
Entity Status
Large Entity
Expires
Nov 20, 2028 (2.7 yr remaining)
Term Adjustment
+716 days (~2.0 yr)
Other
USPTO Event: Expire Patent
Assignments
AssignmentReel/Frame: 019340/0788Recorded: May 24, 2007
From
MILI ABRAMOVInventor
Feb 20, 2007
DINA BEREZOVSKYInventor
Feb 22, 2007
SANTIAGO INIInventor
Feb 18, 2007
ANITA LIBERMANInventor
Mar 19, 2007
ALEXEI PLOUTNOInventor
Feb 15, 2007
OSNAT PORTER-KLEKSInventor
Feb 15, 2007
→
To
TEVA PHARMACEUTICAL INDUSTRIES LTD.
AssignmentReel/Frame: 019156/0123Recorded: Apr 11, 2007
From
MILI ABRAMOVInventor
Feb 20, 2007
DINA BEREZOVSKYInventor
Feb 22, 2007
SANTIAGO INIInventor
Feb 18, 2007
ALEXEI PLOUTNOInventor
Feb 19, 2007
OSNAT PORTER-KLEKSInventor
Feb 15, 2007
→
To
TEVA PHARMACEUTICAL INDUSTRIES LTD.
AssignmentReel/Frame: 019156/0289Recorded: Apr 11, 2007
From
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 27, 2007
→
To
TEVA PHARMACEUTICALS USA, INC.